Production of plasminogen activator by human natural killer cells. Large granular lymphocytes.
Open Access
- 1 March 1984
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 159 (3) , 935-951
- https://doi.org/10.1084/jem.159.3.935
Abstract
Highly purified populations of natural killer (NK) cells: large granular lymphocytes (LGL) were used to demonstrate that freshly isolated and interleukin 2-cultured LGL produce the specific neutral serine protease, plasminogen activator (PA). The enzyme is expressed in both an extracellular form as well as in a cell-associated form. Upon subcellular distribution the latter form of the enzyme is associated with a cell-surface membrane-enriched fraction. LGL PA exists in multiple MW forms ranging from 100,000 to 26,000. Interferon (IFN), the major positive regulator of NK cytolytic activity, caused a substantial enhancement of cell-associated, but not extracellular, PA. In contrast, LGL isolated from patients with Chediak-Higashi syndrome, who are known to be defective in NK activity, displayed low PA activity, altered morphology and low NK killing relative to LGL isolated from nomal donors. The possible role of LGL PA in the lysis of tumor cells by NK cells, either directly or indirectly, is discussed.This publication has 35 references indexed in Scilit:
- Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.Journal of Clinical Investigation, 1982
- Inhibition of plasminogen activator release from transformed chicken fibroblasts by a protease inhibitorCell, 1981
- Characterization of a plasma membrane-associated plasminogen activator on thymocytesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1981
- Characteristics of human large granular lymphocytes and relationship to natural killer and K cellsThe Journal of Experimental Medicine, 1981
- Purification of plasminogen activator from Rous sarcoma virus transformed chick embryo fibroblasts treated with the tumor promoter phorbol 12-myristate 13-acetateBiochemistry, 1980
- Chediak-Higashi gene in humans. I. Impairment of natural - killer functionThe Journal of Experimental Medicine, 1980
- Specific protease deficiency in polymorphonuclear leukocytes of Chédiak-Higashi syndrome and beige mice.The Journal of Experimental Medicine, 1978
- Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells.The Journal of cell biology, 1976
- SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGESThe Journal of Experimental Medicine, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970